The Office of New Drugs at the FDA is in the middle of a major, phased reorganization at the moment. All divisions are impacted, including Neurology, which will be split in two, and Psychiatry.
As part of the reorganization, starting this month, a new Office of Rare Diseases, Paediatrics, Urological & Reproductive Medicine will be formed. In addition, there will be new divisions created for Pharm/Tox for Neuroscience and Pharm/Tox for Rare Diseases, Paediatrics, Urological & Reproductive Medicine.
https://www.fda.gov/drugs/regulator...nges-office-translational-sciences-and-office
The Office of New Drugs at the FDA is in the middle of a major,...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.88 |
Change
-0.140(1.00%) |
Mkt cap ! $1.727B | |||
| Open | High | Low | Value | Volume |
| $13.90 | $14.21 | $13.64 | $4.590M | 329.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 600 | $13.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.96 | 2894 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |